Exchange Traded Concepts’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Buy
7,099
+566
+9% +$111K 0.01% 810
2026
Q1
$1.28M Sell
6,533
-89
-1% -$17.3K 0.01% 732
2025
Q4
$1.15M Sell
6,622
-109
-2% -$19.8K 0.01% 747
2025
Q3
$1.28M Buy
6,731
+258
+4% +$45.8K 0.01% 690
2025
Q2
$1.16M Buy
6,473
+667
+11% +$116K 0.01% 629
2025
Q1
$982K Sell
5,806
-488
-8% -$80.2K 0.02% 566
2024
Q4
$950K Buy
6,294
+116
+2% +$18K 0.02% 584
2024
Q3
$959K Buy
6,178
+942
+18% +$141K 0.02% 527
2024
Q2
$717K Buy
5,236
+255
+5% +$34.9K 0.02% 554
2024
Q1
$663K Buy
4,981
+564
+13% +$73.2K 0.02% 548
2023
Q4
$609K Hold
4,417
0.02% 548
2023
Q3
$538K Buy
4,417
+84
+2% +$11.2K 0.02% 585
2023
Q2
$609K Sell
4,333
-144
-3% -$19.9K 0.02% 532
2023
Q1
$633K Sell
4,477
-183
-4% -$26.2K 0.02% 461
2022
Q4
$729K Buy
4,660
+8
+0.2% +$1.15K 0.02% 371
2022
Q3
$571K Buy
4,652
+33
+0.7% +$4.35K 0.02% 411
2022
Q2
$614K Buy
4,619
+134
+3% +$18.3K 0.02% 414
2022
Q1
$614K Sell
4,485
-13,441
-75% -$1.87M 0.01% 518
2021
Q4
$3.1M Buy
17,926
+17,827
+18,007% +$2.71M 0.06% 187
2021
Q3
$14K Sell
99
-4,196
-98% -$614K ﹤0.01% 985
2021
Q2
$567K Buy
4,295
+681
+19% +$89.2K 0.02% 483
2021
Q1
$464K Buy
3,614
+437
+14% +$53.8K 0.02% 580
2020
Q4
$379K Buy
3,177
+243
+8% +$29.6K 0.02% 472
2020
Q3
$336K Buy
2,934
+85
+3% +$10K 0.02% 428
2020
Q2
$325K Buy
2,849
+2,804
+6,231% +$297K 0.05% 311
2020
Q1
$4K Sell
45
-4
-8% -$414 ﹤0.01% 408
2019
Q4
$5K Buy
+49
New +$5.11K ﹤0.01% 369

Other funds holding DGX

Exchange Traded Concepts's DGX Position: Q2 2026 in Review

Exchange Traded Concepts increased its Quest Diagnostics (DGX) stake by 8.7% in Q2 2026, buying an estimated $111K and bringing the position to 7,099 shares worth $1.5M. The position accounts for 0.01% of the portfolio, ranked #810.

Exchange Traded Concepts first reported a position in DGX in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.1M in Q4 2021. 243 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Exchange Traded Concepts held 7,099 shares of Quest Diagnostics worth $1.5M as of Q2 2026.
  • Exchange Traded Concepts bought 566 Quest Diagnostics shares in Q2 2026, an estimated $111K.
  • Quest Diagnostics made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #810 holding.
  • Exchange Traded Concepts first reported a position in Quest Diagnostics in Q4 2019 and has held it in 27 quarters since.
  • Exchange Traded Concepts's Quest Diagnostics position peaked at $3.1M in Q4 2021.
  • 243 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.